摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-甲氧基苯基)-1-庚酮 | 69287-13-4

中文名称
1-(4-甲氧基苯基)-1-庚酮
中文别名
——
英文名称
1-(4-methoxyphenyl)-1-heptanone
英文别名
1-(4-methoxyphenyl)heptan-1-one;p-Methoxyheptanophenone
1-(4-甲氧基苯基)-1-庚酮化学式
CAS
69287-13-4
化学式
C14H20O2
mdl
——
分子量
220.312
InChiKey
ADNCVBHGESSUHS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    16
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2914509090

SDS

SDS:caebe202dcbced40ad45e9ef89af16f0
查看

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 1-(4-Methoxyphenyl)Heptan-1-One
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 4), H302
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xn Harmful R22
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
H302 Harmful if swallowed.
Precautionary statement(s) none
Supplemental Hazard none
Statements
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

SECTION 3: Composition/information on ingredients
Substances
Molecular weight : 220,31 g/mol
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
1-(4-Methoxyphenyl)Heptan-1-One
Acute Tox. 4; H302 <= 100 %
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
1-(4-Methoxyphenyl)Heptan-1-One
Xn, R22 <= 100 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
No data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Nature of decomposition products not known.
Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
Further information
No data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Storage class (TRGS 510): Non Combustible Solids
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour No data available
c) Odour Threshold No data available
d) pH No data available
e) Melting point/freezing No data available
point
f) Initial boiling point and No data available
boiling range
g) Flash point No data available
h) Evaporation rate No data available
i) Flammability (solid, gas) No data available
j) Upper/lower No data available
flammability or
explosive limits
k) Vapour pressure No data available
l) Vapour density No data available
m) Relative density No data available
n) Water solubility No data available
o) Partition coefficient: n- No data available
octanol/water
p) Auto-ignition No data available
temperature
q) Decomposition No data available
temperature
r) Viscosity No data available
s) Explosive properties No data available
t) Oxidizing properties No data available
Other safety information
No data available

SECTION 10: Stability and reactivity
Reactivity
No data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
No data available
Conditions to avoid
No data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
No data available
Specific target organ toxicity - single exposure
No data available
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

SECTION 12: Ecological information
Toxicity
No data available
Persistence and degradability
No data available
Bioaccumulative potential
No data available
Mobility in soil
No data available
Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
Other adverse effects
No data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
No data available

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
No data available
Chemical Safety Assessment
For this product a chemical safety assessment was not carried out

SECTION 16: Other information
Full text of H-Statements referred to under sections 2 and 3.
Acute Tox. Acute toxicity
H302 Harmful if swallowed.
Full text of R-phrases referred to under sections 2 and 3
Xn Harmful
R22 Harmful if swallowed.
Further information
Copyright 2014 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(4-甲氧基苯基)-1-庚酮 在 palladium on activated charcoal 氢溴酸氢气 作用下, 以 乙醇溶剂黄146 为溶剂, 生成 4-(1-Hexylheptyl)-phenol
    参考文献:
    名称:
    二硝基苯酚衍生物的结构和杀虫活性。第四部分 某些2-(α-支链烷基)-4,6-二硝基和4-(α-支链烷基)-2,6-二硝基苯酚的制备
    摘要:
    通过在醚中缩合2-或4-合成21个2-(α-支链烷基)酚和31个烷基(含5至13个碳原子)的4-(α-支链烷基)酚。酰基苯酚或更易溶的茴香醚与烷基溴化镁的混合物,脱水成烯基衍生物,进行氢化,并在需要时将苯甲醚脱甲基。2-和4-烷基苯酚转化为2-烷基- 4,6-二硝基和4-烷基- 2,6-二硝基酚,用于测试针对苹果的白粉病的致病剂白叉丝单囊壳(埃尔。和大麦Erysiphe graminisMérat和黄瓜Erysiphe cichoracearumMérat的Salm.。
    DOI:
    10.1039/j39670002281
  • 作为产物:
    描述:
    1-(庚-1-炔-1-基)-4-甲氧基苯盐酸 、 sodium sulfide 作用下, 以 甲醇 为溶剂, 反应 60.0h, 以92%的产率得到1-(4-甲氧基苯基)-1-庚酮
    参考文献:
    名称:
    An efficient method for preparation of 3,5-diamino-6-chloropyrazin-2-yl alkyl ketones using a novel acetylene hydration method
    摘要:
    DOI:
    10.1021/jo00266a049
点击查看最新优质反应信息

文献信息

  • One-pot β-alkylation of secondary alcohols with primary alcohols catalyzed by ruthenacycles
    作者:Xu Chang、Low Wei Chuan、Li Yongxin、Sumod A. Pullarkat
    DOI:10.1016/j.tetlet.2012.01.025
    日期:2012.3
    best combination of reactivity and product selectivity among the four. An expanded scope of substrates was also studied with the inclusion of unsaturated primary alcohols. The reactivity trend observed gave insights into the role of hydrogen bonding in the catalytic mechanism involving transfer hydrogenation between the substrates and the transition metal catalyst.
    描述了钌醇循环催化的仲醇与伯醇的一锅式β-烷基化。四个C-N螯合物的调查ruthenacycles经由苯基甲胺的环金属化反应,合成Ñ -methylphenylmethanamine,Ñ,Ñ -dimethylphenylmethanamine,和萘-1-基甲胺与[(η 6 -C 6 H ^ 6)的RuCl 2 ] 2进行了。发现所有四种配合物均与基于苯甲胺的钌环烷有活性,显示出这四种反应性和产物选择性的最佳组合。还研究了包括不饱和伯醇在内的底物的扩大范围。观察到的反应性趋势使人们深入了解了氢键在涉及底物和过渡金属催化剂之间转移加氢的催化机理中的作用。
  • Iron-Catalyzed Highly Enantioselective Hydrogenation of Alkenes
    作者:Peng Lu、Xiang Ren、Haofeng Xu、Dongpo Lu、Yufeng Sun、Zhan Lu
    DOI:10.1021/jacs.1c04773
    日期:2021.8.18
    for the first time an iron-catalyzed highly enantioselective hydrogenation of minimally functionalized 1,1-disubstituted alkenes to access chiral alkanes with full conversion and excellent ee. A novel chiral 8-oxazoline iminoquinoline ligand and its iron complex have been designed and synthesized. This protocol is operationally simple by using 1 atm of hydrogen gas and shows good functional group tolerance
    在这里,我们首次报道了铁催化的高度对映选择性氢化的最低限度官能化的 1,1-二取代烯烃,以获得具有完全转化率和优异ee 的手性烷烃。设计并合成了一种新型手性8-恶唑啉亚氨基喹啉配体及其铁配合物。该协议通过使用 1 个大气压的氢气操作简单,并显示出良好的官能团耐受性。氘标记实验提出了一种主要机制。
  • Pentadieneamides
    申请人:Hoffmann-La Roche Inc.
    公开号:US04788206A1
    公开(公告)日:1988-11-29
    Compounds of the formula ##STR1## Y is O ir S, *A is paraphenylene or *----(CH.sub.2)n----(X).sub.m --(CH.sub.2).sub.r ----, X is O, S or --CH.dbd.CH--, n or r, independently, are integers from 0 to 3, s is an integer from 0 to 1, m is an integer from 0 to 1, provided that when m is 1, n+s must be at least 2, R.sub.1 and R.sub.2, independently, are hydrogen, lower alkyl, cycloalkyl, lower alkenyl, Het, aryl, R.sub.3, R.sub.4 and R.sub.8, independently, are hydrogen, lower alkyl, aryl, R.sub.5 and R.sub.6, independently, are hydrogen or lower alkyl, R.sub.7 is hydrogen, lower alkyl, cycloalkyl, Het-lower alkyl or aryl, Het is a monocyclic 5- or 6-membered hetero aromatic or a bicyclic heteroaromatic radical containing one or two hetero atoms selected from nitrogen, oxygen and sulfur, which radical may be substituted by lower alkyl, halogen or aryl, and the asterisk denotes the point of attachment, and when R.sub.6 and R.sub.7 are different, their enantiomers and racemic mixtures thereof, when R.sub.1 and R.sub.2 are different, their geometric isomers, and pharmaceutically acceptable acid addition salts thereof, are described. The compounds of formula I exhibit activity as platelet activating factor (PAF) antagonists and are, therefore, useful in disease states characerized by excess platelet activating factor or for the prevention and treatment of cardiovascular disease, pulmonary diseases, immunological disorders, inflammatory diseases, dermatological disorders, shock or transplant rejection.
    公式为##STR1##的化合物。其中Y为O或S,*A为对苯基或*----(CH.sub.2)n----(X).sub.m --(CH.sub.2).sub.r ----,X为O、S或--CH.dbd.CH--,n或r独立地为0到3的整数,s为0到1的整数,m为0到1的整数,但当m为1时,n+s必须至少为2,R.sub.1和R.sub.2独立地为氢、低烷基、环烷基、低烯基、Het、芳基,R.sub.3、R.sub.4和R.sub.8独立地为氢、低烷基、芳基,R.sub.5和R.sub.6独立地为氢或低烷基,R.sub.7为氢、低烷基、环烷基、Het-低烷基或芳基,Het为含有一或两个从氮、氧和硫中选择的杂原子的单环5-或6-成员杂芳基或含有一个或两个杂原子的双环杂芳基,该基团可以被低烷基、卤素或芳基取代,星号表示连接点,当R.sub.6和R.sub.7不同时,它们的对映异构体和消旋混合物,当R.sub.1和R.sub.2不同时,它们的几何异构体以及其药学上可接受的酸盐被描述。公式I的化合物表现为血小板活化因子(PAF)拮抗剂的活性,因此,在由于过量血小板活化因子而表现出的疾病状态中或用于预防和治疗心血管疾病、肺部疾病、免疫性疾病、炎症性疾病、皮肤病、休克或移植排斥时,这些化合物是有用的。
  • Selective Iron-Catalyzed Cross-Coupling Reactions of Grignard Reagents with Enol Triflates, Acid Chlorides, and Dichloroarenes
    作者:Bodo Scheiper、Melanie Bonnekessel、Helga Krause、Alois Fürstner
    DOI:10.1021/jo0498866
    日期:2004.5.1
    Cheap, readily available, air stable, nontoxic, and environmentally benign iron salts such as Fe(acac)3 are excellent precatalysts for the cross-coupling of Grignard reagents with alkenyl triflates and acid chlorides. Moreover, it is shown that dichloroarene and -heteroarene derivatives as the substrates can be selectively monoalkylated by this method. All cross-coupling reactions proceed very rapidly
    廉价,容易获得,空气稳定,无毒且对环境无害的铁盐,例如Fe(acac)3是格氏试剂与链烯基三氟甲磺酸酯和酰氯交叉偶联的出色的预催化剂。此外,显示出通过该方法可以将作为底物的二氯亚芳基和-杂亚芳基衍生物选择性地单烷基化。所有交叉偶联反应在特别温和的条件下均能非常快速地进行,结果证明与两个反应伙伴中的各种官能团均相容。对制备结果的详细分析表明,铁催化的碳键形成可以通过不同的途径发生。因此,甲基卤化镁的反应可能包含铁酸盐配合物作为活性成分,而格氏试剂与两个或多个碳原子的反应则受到形式组成[Fe(MgX)2 ]的高度还原的铁簇的影响。n原位生成。使用复杂的[Me 4 Fe] Li 2的对照实验证实了这一解释。
  • Pd-catalyzed Oxidative Cross-coupling of Alkyl Chromium(0) Fischer Carbene Complexes with Organoboronic Acids
    作者:Kang Wang、Jinghui Yang、Xingqi Yao、Jianbo Wang
    DOI:10.1002/asia.201801278
    日期:2018.11.2
    Alkyl chromium(0) carbene complexes have been explored as the cross‐coupling partners in the palladium‐catalyzed reaction with aryl or alkenyl boronic acids. This coupling reaction displays the versatile reactivities of alkyl chromium(0) carbenes under palladium catalysis. Mechanistically, this transformation is proposed to involve deprotonation of the alkyl chromium carbene substrate to generate a
    烷基铬(0)卡宾配合物已被探索为钯与芳基或烯基硼酸催化的交叉偶联伙伴。此偶联反应显示了钯催化下烷基铬(0)卡宾的通用反应性。从机理上讲,提出这种转变涉及烷基铬卡宾底物的去质子化以产生乙烯基铬阴离子中间体,该中间体经历金属转移成有机钯物质并还原消除。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台